Patents by Inventor Jyoti Chattopadhyaya

Jyoti Chattopadhyaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8461124
    Abstract: Conformationally locked 2?,4?-carbocylic nucleosides with improved thermal and nuclease stability are disclosed. Oligonucleotides incorporating the locked nucleosides, and methods of treating disease states, are also disclosed.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: June 11, 2013
    Inventor: Jyoti Chattopadhyaya
  • Publication number: 20110059948
    Abstract: The invention relates to a compound of general formula I, II, III, IV, V, VI, VII, VIII, IX, X or a tautomer and the stereochemically isomeric forms thereof or pharmaceutically acceptable salts thereof, a N-oxide form thereof or a pro-drug thereof. The compound is usable as a medicament for the treatment of mycobacterial disease.
    Type: Application
    Filed: January 9, 2009
    Publication date: March 10, 2011
    Inventors: Jyoti Chattopadhyaya, Ram Shankar Upadhayaya
  • Publication number: 20100087387
    Abstract: Compounds (1, 2, 3, 4) according to the formulae shown below: (Formula 1, 2, 3, 4). For General Formula1-4:N=1-Thyminyl,9-Adeninyl,9-Guaninyl,1-Cytosinyl, 5-methyl-1-cytosinyl, 5-trifluoromethyl-1-cytosinyl, 5-fluoro-1-cytosinyl, 5-fluoro-1-cytosinyl, 5-trifluoromethyl-1-Uracilyl or Formula (A) (12a/12b) wherein for 12a: n=1, Q=CH3(R) [5-membered carbocyclic with C7? in R configuration], 12b: n=1, Q=CH3(S) [5-membered carbocyclic with C7? in S configuration].
    Type: Application
    Filed: March 11, 2008
    Publication date: April 8, 2010
    Inventor: Jyoti Chattopadhyaya
  • Publication number: 20040142946
    Abstract: The present invention relates to modified nucleotides and nucleosides and reagents to produce these. The modified nucleotides and nucleotides are assembled to larger oligonucleotides and oligonucleosides, which, for example, may be used for diagnostics of polymorphisms and for antisense therapy of various conditions. The oligonucleotides and oligonucleosides described in the invention have very good endonuclease resistance without compromising the RNA cleavage properties of RNase H wherein combinations of modifications with Y, Z, R or B are claimed: X=O or S, NH or NCH3, CH2 Or CH(CH3), Y=O, S, or NH or NCH3, CH2or CH(CH3); Z=O, S, or NH or NCH3, CH2 or CH(CH3); R=O or S, or NH or NCH3, CH2 or CH(CH3); B=A, C, G, T; 5-F/cl/BrU or —C, 6-thioguanine, 7-deazaguanine; &agr;- or &bgr;-D- (or L)ribo, xylo, arabino or lyxo configuration.
    Type: Application
    Filed: April 23, 2003
    Publication date: July 22, 2004
    Inventor: Jyoti Chattopadhyaya
  • Patent number: 5721350
    Abstract: Deuterated nucleotide and nucleoside units are used to synthesize strands of RNA and DNA wherein one unit is non-deuterated, with adjacent units deuterated. The deuteration is sufficiently high in order that resonance from the deuterated units do not overlap with resonances from non-deuterated units in NMR-experiments. Thereby a "NMR"-window is created in the DNA or RNA strands, which can be beneficially used for advanced studies of structure versus biological activity in DNA and RNA.
    Type: Grant
    Filed: February 14, 1995
    Date of Patent: February 24, 1998
    Inventor: Jyoti Chattopadhyaya